| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/03/2005 | US20050026211 Compositions and methods relating to lung specific genes |
| 02/03/2005 | US20050026207 CACNA1G polynucleotide, polypeptide and methods of use therefor |
| 02/03/2005 | US20050026191 Nucleotide sequences coding interferon-inducible proteins in fibroblasts for use in diagnosis, prevention and treatment of cell proliferative, nervous system, glandular and inflammatory diseases |
| 02/03/2005 | US20050026188 Methods of identifying, characterizing and comparing organism communities |
| 02/03/2005 | US20050026184 Using serine/threoine kinases (ALK-7) as screening tools in identifying modulators for treatment of nervous system disorders |
| 02/03/2005 | US20050026182 Human CDNAS and proteins and uses thereof |
| 02/03/2005 | US20050026179 For research, biological, clinical and therapeutic purposes, diagnostics |
| 02/03/2005 | US20050026170 Extracellular matrix-binding proteins from Staphylococcus aureus |
| 02/03/2005 | US20050026169 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 02/03/2005 | US20050026165 Identifying and classifying beta beta -sheet conformation of insoluble proteins or prions in a sample; diagnosis and treatment of cell proliferative, urogenital, prion, cardiovascular and pancreactic |
| 02/03/2005 | US20050026162 Compositions and methods for the modification of gene expression |
| 02/03/2005 | US20050026152 Methods of screening for schizophrenia |
| 02/03/2005 | US20050026139 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 02/03/2005 | US20050026136 Hypoxia-mediated neurogenesis |
| 02/03/2005 | US20050025821 Lipid-comprising drug delivery complexes and methods for their production |
| 02/03/2005 | US20050025788 Systemic delivery of non-viral vector expressing SARS viral genomic vaccine |
| 02/03/2005 | US20050025787 Transformed bacteria producing CS6 antigens as vaccines |
| 02/03/2005 | US20050025784 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/03/2005 | US20050025782 Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof |
| 02/03/2005 | US20050025781 Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof |
| 02/03/2005 | US20050025779 Immunogenic gp120 polypeptides and polynucleotides; expression vectors and host cells; medical diagnosis; vaccines |
| 02/03/2005 | US20050025776 Vascular inflammatory disorders, atherosclerosis, arteritis or reperfusion injury, autoimmune, nervous system and connective tissue disorders, rheumatoid arthritis, meningitis, multiple sclerosis, inflammatory bowel disorders, ulcerative colitis and Crohn's disease |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025773 Blocked immunoglobulin comprising antibody portion having heavy or light chain variable region; and Protein A portions; tethered to solid support; antibody sandwich, enzyme-linked immunosorbent, antibody dipstick, antibody microarray, radioimmuno-, or rolling circle amplification assay |
| 02/03/2005 | US20050025772 Monoclonal antibody 108-394 binds to shared epitope of protein p24 and protein p26; diagnostic kits; conjugate of antibody attached to a signal generating compound; sensitivity |
| 02/03/2005 | US20050025770 Immunological methods for the treatment of gastrointestinal cancer |
| 02/03/2005 | US20050025763 Therapeutic use of anti-CS1 antibodies |
| 02/03/2005 | US20050025758 Method and compositions for treatment of insulin-dependant diabetes mellitus |
| 02/03/2005 | US20050025754 Immunosuppression of lymphocytes by introducing a cDNA molecule encoding mutant LIGHT into the tumor, and expressing the cDNA molecule; antitumor agents, tumor antigens; drug screening |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | US20050025745 Using a Bifidobacterium as a gene delivery vector for a recombinant DNA in combination with an antitumor agent to tumor tissues under anaerobic conditions |
| 02/03/2005 | US20050025723 Topical formulation containing melanocyte stimulating hormone and/or derivative in carrier |
| 02/03/2005 | CA2850891A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | CA2533858A1 Compositions and methods for treating cardiac dysfunction |
| 02/03/2005 | CA2533479A1 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 02/03/2005 | CA2533113A1 Soluble fragments of the sars-cov spike glycoprotein |
| 02/03/2005 | CA2532994A1 C5a receptor antagonists |
| 02/03/2005 | CA2532869A1 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/03/2005 | CA2532430A1 Humanized versions of monoclonal antibody ds6 that bind tumour antigen ca6 |
| 02/03/2005 | CA2532370A1 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | CA2532250A1 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 02/03/2005 | CA2532035A1 Fugetactic proteins, compositions and methods of use |
| 02/03/2005 | CA2531491A1 Agonist polypeptide of receptor for zot and zonulin |
| 02/03/2005 | CA2531073A1 Human mast cell-expressed membrane protein |
| 02/03/2005 | CA2530284A1 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | CA2530085A1 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | CA2529369A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | CA2528458A1 A method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 02/03/2005 | CA2528440A1 Replikin peptides and uses thereof |
| 02/03/2005 | CA2526814A1 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | CA2526240A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 02/03/2005 | CA2517600A1 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/02/2005 | EP1503212A1 Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/02/2005 | EP1502949A1 Antimicrobial polypeptide and utizliation thereof |
| 02/02/2005 | EP1502921A1 Recombinant mutated human factor VIII (FVIII) with improved stability |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1502919A1 Method for obtaining agents against insects by using the structural coordinates of ZAD grau |
| 02/02/2005 | EP1502602A2 Methods for therapeutic vaccination |
| 02/02/2005 | EP1502600A1 Use of botulinum toxin for treating smooth muscle disorders |
| 02/02/2005 | EP1502599A1 Active antiangiogenic therapy |
| 02/02/2005 | EP1502116A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 02/02/2005 | EP1502115A2 Method of identifying ligands for nuclear receptors |
| 02/02/2005 | EP1502114A1 THE METHOD FOR MEASURING THE AMOUNT OF $g(b)iG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME |
| 02/02/2005 | EP1502110A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 02/02/2005 | EP1501948A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/02/2005 | EP1501942A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501935A2 Low-cost production of peptides |
| 02/02/2005 | EP1501926A2 Polynucleotides encoding novel two splice variants of a human cell surface protein with immunologobulin folds, bgs5g and bgs5i |
| 02/02/2005 | EP1501925A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 02/02/2005 | EP1501921A1 Improved viral purification methods |
| 02/02/2005 | EP1501871A2 Isolated human proteins that show high homology to human disease proteins, nucleic acid molecules encoding these human proteins, and uses thereof |
| 02/02/2005 | EP1501869A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/02/2005 | EP1501868A1 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same |
| 02/02/2005 | EP1501867A1 Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha) |
| 02/02/2005 | EP1501866A2 Apo-2 ligand variants and uses thereof |
| 02/02/2005 | EP1501865A1 Crystal structure of acetyl choline binding protein |
| 02/02/2005 | EP1501864A1 Metallo proteinase inhibitory agent |
| 02/02/2005 | EP1501863A2 Kinase anchor protein muteins, peptides thereof, and related methods |
| 02/02/2005 | EP1501862A2 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 02/02/2005 | EP1501861A1 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1501855A2 Novel compositions and methods in cancer |
| 02/02/2005 | EP1501544A2 Alcam and alcam modulators |
| 02/02/2005 | EP1501543A1 Use of modified novirhabdoviruses to obtain vaccines |
| 02/02/2005 | EP1501542A1 Improved polysaccharide and glycoconjugate vaccines |
| 02/02/2005 | EP1501538A2 Use of alpha-s2 casein precursor-derived peptides |
| 02/02/2005 | EP1501537A1 Mannose binding lectin and uses thereof |
| 02/02/2005 | EP1501536A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/02/2005 | EP1501529A1 Mammalian genes modulated during fasting and feeding |
| 02/02/2005 | EP1461620A4 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 02/02/2005 | EP1432810A4 Production of recombinant proteins in vivo and use for generating antibodies |
| 02/02/2005 | EP1432451A4 Production of fusion proteins and use for identifying binding molecules |
| 02/02/2005 | EP1390379A4 Kindling fluorescent proteins and methods for their use |
| 02/02/2005 | EP1372686B1 Methods and compositions for peptide synthesis |
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | EP1295123A4 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 02/02/2005 | EP1285269B1 Lipid uptake assays |
| 02/02/2005 | EP1268824B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |